Longhorn Vaccines and Diagnostics Honors World TB Day 2025, Underscoring a Commitment to Eradicating Tuberculosis with PrimeStore® MTM
Longhorn Vaccines and Diagnostics, a One Health company developing vaccines and diagnostic tools for global public health and zoonosis concerns, today honors World Tuberculosis (TB) Day 2025 by ...
Hosted on MSN3mon
WHO gives first approval of TB test
Xpert MTB/RIF Ultra, produced by US-based molecular diagnostics company Cepheid, "is the first test for TB diagnosis and antibiotic susceptibility testing that meets WHO's prequalification ...
Medscape1mon
Evaluation of the Xpert MTB/RIF Test for the Diagnosis of Childhood Pulmonary Tuberculosis in Uganda
In the policy statement on the Xpert MTB/RIF test in 2011, the WHO recommended the use of the test as an initial diagnostic tool among children with suspected HIV associated TB or MDR TB based on ...
Morningstar2d
Longhorn Vaccines and Diagnostics Honors World TB Day 2025, Underscoring a Commitment to Eradicating Tuberculosis with PrimeStore® MTM
PrimeStore helps solve these issues by offering a superior, biohazard-free sample collection solution compatible with all major molecular testing platforms including GeneXpert MTB/RIF Ultra.